GENE ENGINEERING AND COMBINATIONAL BIOLOGY

基因工程和组合生物学

• 批准号: 6653848
• 负责人: Kevin A. Jarrell
• 金额: $ 28万
• 依托单位: MODULAR GENETICS, INC.
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-03-15 至 2006-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6653848
• 关键词: RNA splicing; biotechnology; enzyme biosynthesis; fusion gene; genetic library; genetic manipulation; genetic recombination; genetic techniques; mass spectrometry; molecular cloning; nucleic acid sequence; peptide library; polymerase chain reaction; ribozymes; technology /technique development

DESCRIPTION (Investigator's Abstract): The research program described in this application is focused on the development and implementation of new gene engineering methods. The methods that are being developed are particularly suited to the manipulation of modular genes, such as peptide synthetic genes. Our goal is to break the modular genes up into their component modules, and use those modules as building blocks for the assembly of novel new modular genes. To achieve this goal, we have developed two new approaches to gene engineering. Both approaches will be optimized and implemented during the funding period. The first approach involves the use of ribozymes(i.e., enzymes comprised of RNA) as tools for chimeric gene assembly. The second approach involves the use of RNA-overhang cloning (ROC) and NA-overhang cloning (DOC) to create chimeric genes. Finally, the ribozyme method will be combined with the ROC and OCmethods to create a new gene engineering system that takes full advantage of the strengths of the individual approaches. Efficient gene engineering methods are of fundamental importance for both basic and applied research on topics directly relevant to human health. For example, the gene engineering methods described here will be used to create combinatorial gene libraries that encode chimeric peptide synthetase genes. Naturally occurring peptide synthetases are known to synthesize important antibiotics, such as penicillin and vancomycin. Furthermore, the immunosuppressant cyclosporine is produced by a peptide synthetase. The chimeric peptide synthetase genes generated during the course of this project should encode hybrid enzymes that synthesize novel biologically active-molecules. A long-term goal of this project is to screen chimeric gene libraries to identify enzymes that synthesize novel compounds at could be developed as drugs.

描述（研究者摘要）：本研究中描述的研究项目 应用的重点是新基因的开发和实施 工程方法正在开发的方法特别是 适合于操纵模块基因，如肽合成基因。 我们的目标是将模块化基因分解成它们的组成模块， 这些模块作为组装新的模块基因的基石。 为了实现这一目标，我们开发了两种新的基因工程方法。 这两种方法都将在供资期间得到优化和实施。 第一种方法涉及使用核酶（即，酶包括 RNA）作为嵌合基因组装的工具。第二种方法涉及使用 RNA-突出端克隆（ROC）和NA-突出端克隆（DOC）以产生嵌合的 基因.最后，将核酶法与ROC和OC法相结合， 创造一个新的基因工程系统， 个人方法的优势。 有效的基因工程方法对于两种基本的 以及与人类健康直接相关的应用研究。例如，在一个示例中， 本文所述的基因工程方法将用于产生 编码嵌合肽合成酶基因的组合基因文库。 已知天然存在的肽合成酶合成重要的肽， 抗生素，如青霉素和万古霉素。而且 免疫抑制剂环孢菌素由肽合成酶产生。的 嵌合肽合成酶基因在这个项目的过程中产生 应该编码杂合酶， 活性分子本项目的长期目标是筛选嵌合基因 库来识别合成新化合物的酶， 发展为毒品。